Sherlock Biosciences Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 33

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $28.3M

  • Investors
  • 2

Sherlock Biosciences General Information

Description

Developer of a diagnostic platform designed to control disease in low-resource settings. The company's platform uses engineering biology tools, including CRISPR and synthetic biology, to create a new generation of molecular diagnostics, enabling healthcare providers to rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 200 Talcott Avenue
  • Watertown, MA 02472
  • United States
+1 (617)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Parent Company
Corporate Office
  • 200 Talcott Avenue
  • Watertown, MA 02472
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sherlock Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 19-Dec-2024 $28.3M Completed Generating Revenue
7. Grant 06-Oct-2023 Completed Generating Revenue
6. Early Stage VC (Series B) 28-Feb-2022 Completed Generating Revenue
5. Grant 16-Dec-2020 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2020 Completed Startup
3. Early Stage VC (Series A) 23-Apr-2019 Completed Startup
2. Grant 21-Mar-2019 $17.5M Completed Startup
1. University Spin-Out 01-Mar-2019 Completed Startup
To view Sherlock Biosciences’s complete valuation and funding history, request access »

Sherlock Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Sherlock Biosciences’s complete cap table history, request access »

Sherlock Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a diagnostic platform designed to control disease in low-resource settings. The company's platform uses eng
Diagnostic Equipment
Watertown, MA
33 As of 2025

San Diego, CA
 

Santa Cruz, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sherlock Biosciences Competitors (25)

One of Sherlock Biosciences’s 25 competitors is Illumina, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Illumina Formerly VC-backed San Diego, CA
SomaGenics Corporation Santa Cruz, CA
Foundation Medicine Formerly VC-backed Boston, MA
Synthego Venture Capital-Backed Redwood City, CA
Bio-Rad Laboratories Corporation Hercules, CA
You’re viewing 5 of 25 competitors. Get the full list »

Sherlock Biosciences Patents

Sherlock Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026015653-A2 Power-free fluidic device Pending 09-Jul-2024
WO-2026015653-A3 Power-free fluidic device Pending 09-Jul-2024
EP-4720336-A1 Condensed loop-mediated isothermal amplification Pending 01-Jun-2023
WO-2024249878-A1 Condensed loop-mediated isothermal amplification Inactive 01-Jun-2023
AU-2024245317-A1 In vitro diagnostic system Pending 31-Mar-2023 B01L3/502715
To view Sherlock Biosciences’s complete patent history, request access »

Sherlock Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sherlock Biosciences Former Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
10X Capital Venture Capital Minority
A-Level Capital Venture Capital Minority
Albany Capital (Australia) Venture Capital Minority
Baidu Ventures Corporate Venture Capital Minority
Catalio Capital Management Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

Sherlock Biosciences Acquisitions (1)

Sherlock Biosciences’s most recent deal was a Merger/Acquisition with Sense Biodetection. The deal was made on 01-Feb-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sense Biodetection 01-Feb-2023 Merger/Acquisition Diagnostic Equipment
To view Sherlock Biosciences’s complete acquisitions history, request access »

Sherlock Biosciences Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Sense Biodetection Abingdon, United Kingdom 2014

Sherlock Biosciences FAQs

  • When was Sherlock Biosciences founded?

    Sherlock Biosciences was founded in 2019.

  • Where is Sherlock Biosciences headquartered?

    Sherlock Biosciences is headquartered in Watertown, MA.

  • What is the size of Sherlock Biosciences?

    Sherlock Biosciences has 33 total employees.

  • What industry is Sherlock Biosciences in?

    Sherlock Biosciences’s primary industry is Diagnostic Equipment.

  • Is Sherlock Biosciences a private or public company?

    Sherlock Biosciences is a Private company.

  • What is the current valuation of Sherlock Biosciences?

    The current valuation of Sherlock Biosciences is .

  • What is Sherlock Biosciences’s current revenue?

    The current revenue for Sherlock Biosciences is .

  • How much funding has Sherlock Biosciences raised over time?

    Sherlock Biosciences has raised $113M.

  • Who are Sherlock Biosciences’s investors?

    10X Capital, A-Level Capital, Albany Capital (Australia), Baidu Ventures, and Catalio Capital Management are 5 of 17 investors who have invested in Sherlock Biosciences.

  • Who are Sherlock Biosciences’s competitors?

    Illumina, SomaGenics, Foundation Medicine, Synthego, and Bio-Rad Laboratories are some of the 25 competitors of Sherlock Biosciences.

  • When was Sherlock Biosciences acquired?

    Sherlock Biosciences was acquired on 19-Dec-2024.

  • Who acquired Sherlock Biosciences?

    Sherlock Biosciences was acquired by Orasure Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process